Fred Alger Management released its Q4 2025 investor letter, highlighting the strong performance of the Alger Small Cap Focus Fund. The US equity market surged 2.7% in Q4, driven by better-than-expected corporate earnings and the Federal Reserve’s interest rate easing stance. The Fund outperformed the Russell 2000 Growth Index, with strong contributions from the Utilities and Financials sectors.

Natera, Inc. (NASDAQ:NTRA) was featured in the Alger Small Cap Focus Fund’s investor letter for Q4 2025. The company is a leading diagnostics and research firm with significant growth potential. Natera, Inc. stock closed at $231.25 on January 16, 2026, with a market cap of $32.248 billion. The stock has gained 46.03% over the last 52 weeks.

Alger Small Cap Focus Fund provided positive commentary on Natera, Inc. in its Q4 2025 investor letter, highlighting the company’s strong financial performance. Natera offers genetic testing services in reproductive health, oncology, and transplant diagnostics. The company reported robust earnings in Q3, exceeding revenue and margin expectations.

While Natera, Inc. is not among the 30 most popular stocks among hedge funds, it remains a solid investment option. The company generated $592 million in revenue in Q3 2025, marking a 35% increase from the previous year. While AI stocks offer upside potential, Natera’s growth trajectory and market position make it an attractive investment opportunity.

For more insights on high-growth stocks and hedge fund investor letters, check out related articles. Stay informed about the best and worst Dow stocks for the next 12 months and explore unstoppable stocks that could double your money. This article was originally published on Insider Monkey and does not contain any disclosures.

Read more at Yahoo Finance: Natera (NTRA) Surged as Results Beat Expectations